PHIO

$1.22+0.04 (+3.39%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

Recent News

PHIO Stock Analysis & Real-Time Data | Whystock